Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 9, 2022
Information needs of patients considering oral immunotherapy for food allergyDouglas Paul Mack, Matthew Greenhawt, Paul J Turner, et al.
JAMA Internal Medicine|February 21, 2022
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysisDerek K Chu, Elissa M Abrams, David B K Golden, et al.
Allergy|April 25, 2022
Psychometric parameters of food allergy quality of life during an allergen immunotherapy trialGabriel Lins de Holanda Coelho, Audrey DunnGalvin, Matthew Greenhawt, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 15, 2020
Development and acceptability of a shared decision-making tool for commercial peanut allergy therapiesMatthew Greenhawt, Marcus Shaker, Tonya Winders, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2024
Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to EveryoneAlexandra E Conway, Jay Lieberman, Christopher D Codispoti, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2026
What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial DiseaseAlicia Μ Johnston, Nicholas L Rider, Alexandra F Freeman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 15, 2025
Compassionomics: Translating Evidence-Informed Patient-Centered Care to the Allergy Immunology ClinicDon Bukstein, Alan P Baptist, Alexandra E Conway, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2025
Barriers and Solutions to Optimal Food Allergy Prevention, Diagnostic, and Management StrategiesSteve A Tilles, Daniel C Adelman, Matthew Greenhawt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2021
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of AnaphylaxisMarcus Shaker, Elizabeth Phillips, Kimberly G Blumenthal, et al.
Pageof 13